Protection of Renal Tubular Cells by Antioxidants: Current Knowledge and New Trends by Baradaran, A. et al.
          CELL JOURNAL(Yakhteh), Vol 16, No 4, Winter 2015 568
Letter to The Editor
Protection of Renal Tubular Cells by Antioxidants: 
Current Knowledge and New Trends
 
Azar Baradaran, Ph.D.1, Hamid Nasri, M.D.2, Mahmoud Rafieian-Kopaei, Ph.D.3*
1. Department of Pathology, Isfahan University of Medical Sciences, Isfahan, Iran
2. Department of Nephrology, Division of Nephropathology, Isfahan University of Medical Sciences, Isfahan, Iran
3. Medical Plants Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran 
*Corresponding Address: Medical Plants Research Center, Shahrekord University of Medical Sciences, Sharekord, Iran
Email: rafieian@yahoo.com
Received: 20/Aug/2013, Accepted: 25/Dec/2013
Abstract
Acute renal damage mainly develops following toxic or ischemic insults and is defined as 
acute. These damages have largely been attributed to oxidative stress. Recently much 
attention has been directed toward decreased renal tubular cell regeneration during tu-
bular cell injury. Antioxidants have recently been the focus of researchers and scientists 
for prevention and treatment of various oxidative stress-related conditions, including renal 
toxicities. Although free radicals are known to contribute in kidney injury and abundant 
researches, particularly laboratory trials, have shown the beneficial effects of antioxidants 
against these complications, long term clinical trials do not uniformly confirm this matter, 
especially for single antioxidant consumption such as vitamin C. The aim of this paper is 
to discuss the possible explanation of this matter.
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Acute renal damage mainly develops following 
toxic or ischemic insults and is defined as acute 
tubular cell injury and kidney dysfunction (1-3). 
However, the pathogenesis of acute renal injury is 
complex and promoting events may be completely 
different, similar pathways may be concerned in 
subsequent injury responses (4-8). Recently much 
attention has been directed toward decreased re-
nal tubular cell regeneration during tubular cell 
injury. Indeed, nowadays attentions are mostly 
on prevention, protection as well as acceleration 
of tubular cells regeneration against injurious in-
sults to the kidney. To study acute kidney injury 
(AKI) models, various methods have been defined 
for each specific condition. Gentamicin (GM) de-
rived from gram-positive bacteria has potential in 
treating aerobic gram-negative bacteria. However, 
GM has been extensively used for induction of 
AKI in preclinical investigations and evaluation 
of renal protective agents. Accumulation of GM in 
kidney proximal tubular cells may trigger renal in-
jury which leads to brush border network damage 
(9-11). The kidney toxicity involves production 
and acceleration of kidneys free radical, utiliza-
tion of antioxidant defense mechanisms and acute 
renal tubular cells necrosis (9-12), which leads to 
diminished glomerular filtration rate (GFR) and 
kidney dysfunction. The pathological mecha-
nisms also involve up-regulation of transforming 
growth factor-beta (TGF-β), rise of endothelin-1, 
augmentation of oxidative stress, significant in-
crease in monocyte/macrophage infiltration into 
the renal cortex and medulla, apoptosis and even-
tually necrosis (10-15). GM has also been shown 
to amplify the generation of superoxide anions, 
hydroxyl radicals, reactive oxygen species (ROS) 
and hydrogen peroxide in proximal tubular cells, 
leading to kidney damage (9, 10). Most research-
ers against GM renal toxicity, therefore, focused 
on the use of various antioxidants such as vitamins 
C and E or antioxidants of medicinal plants (9, 10). 
Indeed role of renal mitochondria against GM-
nephrotoxicity protection, the role of antioxidants 
in either protecting or mitigating GM renal toxic-
ity, as well as integrative glomerular and tubular 
effects and their possible interplay have been de-
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scribed. Oxidative stress reflects the imbalance 
between the level of production and removal of 
cell oxidants. In oxidative stress, an increase in 
ROS and reactive nitrogen species (RNS) and/
or decrease in body antioxidants (exogenous/
endogenous) will happen. This imbalance sup-
presses the ability of biological systems in de-
toxification of the reactive intermediates or in 
repair of the resulting damage. Thus it should 
be noted that GM administration can easily 
induce severe renal toxicity, which is used to 
study drug-induced acute kidney damage. This 
complication has been attributed to generation 
of ROS in the kidney. In fact, AKI is a common 
clinical entity with high mortality and morbid-
ity rates (8-11). A large number of patients also 
have other complications such as diabetes, vas-
cular disease or chronic renal failure which put 
them at higher risk of AKI due to ischemic and 
nephrotoxic insults (11-15). Recently medicinal 
plants have been the focus of researchers and 
scientists for prevention and treatment of vari-
ous oxidative stress-related conditions (8, 16). 
Medicinal plants possess a lot of phytochemi-
cals with antioxidant properties including phe-
nolic and carotenoid compounds (17, 18). Ca-
rotenoid consumption has been shown to reduce 
the risk of several chronic and degenerative 
complications (19). Phenolic compounds are 
abundantly presented in medicinal plants and 
food products and mainly consisted of antho-
cyanins, phenolic acids, tannins and flavonoids. 
These compounds possess a wide range of an-
tioxidant activities (20, 21). Kidney damage 
induced by oxidative stress is associated with 
increased ROS/RNS production which is sig-
nificantly prevented by antioxidants (8, 19-22). 
Medicinal plants-derived antioxidants enhance 
endogenous antioxidants ability to protect renal 
damage through reduction of lipid peroxidation 
(LPO) (23, 24). Tocotrienol, a member of vi-
tamin E family with antioxidant activity, sup-
plementation has been shown to increase glu-
tathione (GSH) level and catalase activity and 
reduce renal LPO, resulting in proximal tubular 
injury. Moreover, it is capable of improving the 
index of NO2-/NO3- generation. Tocotrienol 
has also shown to protect the kidney damage in-
duced by potassium dichromate (23). Ligustra-
zine which is an alkaloid extracted from ligusti-
cum wallichii possesses antioxidant property. It 
is capable of protecting kidneys from ischemia/
reperfusion injuries by reducing malondialde-
hyde (MDA), decreasing ROS generation and 
elevating superoxide dismutase (SOD) activity. 
Troxerutin has been shown to reduce oxida-
tive stress-induced kidney damage. It is abun-
dantly found in tea, coffee, cereal grain and a 
variety of vegetables and fruits, while is able 
to reduce MDA level and enhances antioxidant 
enzyme activities, including SOD, glutathione 
peroxidase (GPx), Cu/Zn and catalase (24, 25). 
As mentioned, antioxidants usually act by giv-
ing electrons to free radicals and trying to turn 
them neutral. It has been elucidated that peo-
ple who intake low vegetables and fruits are at 
greater risk of developing some complications. 
Although free radicals are known to contribute 
in kidney injury (26, 27), heart disease; diabe-
tes (19-27), atherosclerosis (20-28), nephrotox-
icity, hepatotoxicity, cognition (21-28), vision 
loss (29) and abundant researches, particularly 
laboratory trials, have shown the beneficial ef-
fects of antioxidants against these complica-
tions, long term clinical trials do not uniformly 
confirm this matter (30). It seems that the mol-
ecules which found naturally in grains, vegeta-
bles and fruits usually act to prevent a variety of 
conditions such as kidney injury, but not all an-
tioxidants in different conditions act the same. 
There is little evidence indicating taking sin-
gle antioxidant such as vitamin C or E is clini-
cally able to protect against kidney injury as 
well as other oxidative stress-related complica-
tions (28-30). The findings about consumption 
of antioxidant combinations are not entirely 
clear (30-34). In this regard, it is not clear why 
single or even combination of antioxidants do 
not act the same as antioxidants in vegetables 
and fruits. The possible explanation is that an-
tioxidants usually act as parts of complicated 
networks, and therefore, single antioxidant can-
not do the same as the whole natural products 
(8, 16, 30, 31, 35). Although it has been eluci-
dated that eating grains, vegetables, and fruits 
which are rich in antioxidants provides protec-
tion against oxidative stress-related complica-
tions such as kidney injury, but this does not 
mean that antioxidants will prevent or fix the 
problem, especially not when they are taken out 
of their natural context. Notably, the results of 
various researches are inconclusive; however, 
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most of the studies have had limitations such as 
short duration and conducting on patients with 
existing diseases.
Conclusion
Oxidative stress is contributed to kidney dam-
age by increasing oxidative stress, particularly 
insufficiency of endogenous antioxidant defense 
system.  Antioxidant activity of medicinal plants 
has been demonstrated to prevent oxidative kidney 
damage by reduction of LPO and by an increase 
in scavenging ability of antioxidant defense sys-
tem. Consumption of medicinal plants seems to 
be important remedies to abrogate pathology of 
oxidative stress-related complications, like kidney 
injury, while these antioxidants usually act as parts 
of complicated networks and therefore, single an-
tioxidant cannot do the same as the whole natural 
products. Although it has been elucidated that eat-
ing grains, vegetables, and fruits provides protec-
tion against oxidative stress-related complications 
such as kidney injury, but this does not mean that 
antioxidants will prevent or fix the problem, espe-
cially not when they are taken out of their natural 
context.
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